Clinical trial
Study of BMN-673 With Carboplatin and Paclitaxel in Patients With Advanced BRCA-mutated Solid Tumor or Triple Negative Metastatic Breast Cancer
NCT02358200
Study timeline
Study start (actual)2015-02-23Date precision: day
Registry last updated2020-01-10
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Triple Negative Metastatic Breast Cancerunresolved
BRCA-mutated Solid Tumorunresolved
Interventions
BMN-673DRUG
CarboplatinDRUG · verified · RxNorm: carboplatin
PaclitaxelDRUG · verified · RxNorm: paclitaxel
Sponsors & collaborators
Pamela Munsterlead sponsor
QuantumLeap Healthcare Collaborativecollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02358200 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.